Liquid medications guidelines

TB-4 Certification for Exchange Product or Customer Pickup of Bulk Medical Liquids, Gives guidelines for uniform bulk product loading iden-... 

If liquid/droplet exposure is known or suspected in an individual exhibiting miosis only or miosis and rhinorrhea only, it is recommended that the individual receive no antidote treatment but be closely observed for at least 18 h, because toxic effects of liquid percutaneous exposure may not manifest for several hours (Sidell, 1997 Cannard, 2006). Toxic effects from vapor-only exposure usually occur quickly (within minutes) (Sidell, 1997). Current medical management guidelines and recommended medication protocols are summarized in ATSDR (2007), Vale et al. (2007), and Pulley and Jones (2008). The ATSDR antidote treatment protocol for civilian emergency management is summarized in Table 9.7. For additional information about antidotal treatment, readers are referred to Chapters 67, 68, and 71 of this volume. 

---